In ruminants, the elongating conceptus secretes interferon tau (IFNT), the pregnancy recognition signal, and prostaglandins (PGs). Progesterone from the ovary induces prostaglandin synthase two (PTGS2) and hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1) in the endometrial epithelia, and PTGS2-derived PGs regulate endometrial functions and conceptus elongation. The enzyme HSD11B1 interconverts inactive cortisone and active cortisol. These studies determined the effects of pregnancy, IFNT, and PGs on endometrial HSD11B1 expression and activity in the ovine uterus. Study one found that HSD11B1 activity was present in both the endometrium and conceptus during early pregnancy. In study two, ewes received intrauterine infusions of vehicle as a control (CX) or meloxicam (MEL), a PTGS2 inhibitor, from Days 8 to 14 of pregnancy. Endometrial HSD11B1 activity and cortisol in the uterine lumen were substantially lower in MEL-infused ewes. In study three, cyclic ewes received intrauterine infusions of vehicle as a CX, MEL, recombinant ovine IFNT, or IFNT and MEL. Infusion of IFNT increased endometrial HSD11B1 expression and activity and cortisol in the uterine lumen, and this effect was diminished by coinfusion of MEL. In study four, cyclic ewes were infused with vehicle as a CX, IFNT, PGE2, PGF2 alpha, or PGI2. Infusion of all the PGs and IFNT increased endometrial HSD11B1 expression and activity, and IFNT and PGI2 infusion increased cortisol in the uterine lumen. These studies support the idea that IFNT and PGs from the conceptus regulate endometrial HSD11B1 expression and activity that regenerates bioactive cortisol in the ovine uterus during early pregnancy to influence endometrial functions and conceptus elongation.
INTRODUCTION
Maternal support of blastocyst growth and development into an elongated conceptus (embryo/fetus and associated membranes) is critical for pregnancy recognition signaling and implantation in ruminants [1, 2] . After hatching from the zona pellucida on Day 8, the blastocyst develops into an ovoid or tubular form by Days 11 to 12 and is then termed a conceptus [1, 3] . The conceptus begins to elongate on Day 12 and is up to 14 cm or more in length by Day 16. Conceptus elongation requires substances secreted predominantly by the endometrial luminal epithelia (LE) and glandular epithelia (GE) [4, 5] . During early pregnancy in ruminants, functions of the endometrium are regulated primarily by progesterone (P4) from the corpus luteum (CL) and secreted factors from the conceptus, including interferon tau (IFNT) and prostaglandins (PGs) [6] [7] [8] [9] . In both sheep and cattle, IFNT silences expression of estrogen receptor alpha (ESR1) to prevent up-regulation of oxytocin receptor (OXTR) expression in the endometrial LE and superficial GE (sGE), which is required for the endometrium to generate oxytocin-dependent luteolytic pulses of prostaglandin F2 alpha (PGF2a) in response to oxytocin in nonpregnant ewes [10] . In this way, IFNT maintains CL function for continued production of P4, the unequivocal hormone of pregnancy that stimulates and maintains endometrial functions necessary for conceptus survival and growth [9] . Ovarian P4 induces and IFNT and PGs stimulate expression of many genes implicated in regulation of conceptus growth and development during the peri-implantation period of pregnancy (see [8, 9, [11] [12] [13] for review and [14] ).
Using an ovine model of accelerated blastocyst growth and conceptus development, HSD11B1 (11b-hydroxysteroid dehydrogenase 1) was found to be a P4-regulated gene implicated in elongation of the conceptus [15] . Endometrial HSD11B1 expression was induced by P4 and stimulated by IFNT in the endometrial LE/sGE of the ovine uterus [16] . Expression of HSD11B1 is also up-regulated in the endometrium of cattle between Days 7 and 13 of pregnancy during conceptus elongation [17] . HSD11B1 is one of two isoforms of the HSD11Bs that regulate intracellular levels of bioactive glucocorticoids within key target tissues [18] . HSD11B1 is a low affinity NADP(H)-dependent bidirectional dehydrogenase/ reductase for glucocorticoids. The direction of HSD11B1 activity is determined by the relative abundance of NADP þ and NADPH cofactors. In the presence of a high NADPH to NADP þ ratio, which can be generated by hexose-6-phosphate dehydrogenase (H6PD), HSD11B1 acts predominately as a keto-reductase to generate active cortisol from inactive cortisone [18] . In contrast, HSD11B2 is a high-affinity NADPH-dependent unidirectional dehydrogenase that metabolizes active cortisol to inactive cortisone. HSD11B2 mRNA is detectable at very low levels in all endometrial cell types during estrous cycle and pregnancy of ewes, but is particularly abundant in conceptus trophectoderm [16] . Thus, two isoforms of HSD11B enzymes regulate cortisol regeneration or inactivation in the ovine endometrium and conceptus. Cortisol regulates gene expression via the glucocorticoid receptor (nuclear receptor subfamily 3, group C, member 2 or NR3C1 or GR). NR3C1 protein is present in all endometrial cells of ovine uterus during the estrous cycle and pregnancy and in the conceptus trophectoderm [14] [15] [16] .
We recently reported that PGs mediate, in part, P4 induction and IFNT stimulation of HSD11B1 expression in the ovine endometrium [14] . Similarly, PGs regulate activity of HSD11B1 in bovine endometria [19] , and PGF2a stimulates the activity of HSD11B1 in human fetal membranes [20, 21] . Whereas PGs stimulate HSD11B1 activity, glucocorticoids enhance PG synthesis by up-regulating expression and activity of phospholipase A2 and prostaglandin G/H synthase and cyclooxygenase 2 (PTGS2) in the ovine placenta, thereby establishing a positive feed-forward loop implicated in the timing of parturition [22] . This tissue-specific stimulatory role of glucocorticoids on PG synthesis contradicts the classical concept that glucocorticoids exert anti-inflammatory effects on immune cells [23] . During early pregnancy, the endometrial LE/sGE and conceptus trophectoderm express PTGS2 in sheep [24, 25] . Endometrial epithelial HSD11B1 mRNA expression is markedly up-regulated during the period of conceptus elongation in sheep [16] , which is coincident with increased expression of PTGS2 and secretion of PGs by the conceptus [24] [25] [26] . Between Days 12 and 16 of pregnancy, ovine conceptuses release mainly cyclooxygenase metabolites, including PGE2, PGF2a, and PGI2 [25, 27, 28] . Intrauterine infusion of meloxicam (MEL), a PTGS2 inhibitor, reduces HSD11B1 expression in ovine endometrium, suggesting that cortisol likely plays a role in mediating mechanisms responsible for conceptus elongation via its effects on the endometrium and, perhaps, the conceptus [14] .
Available evidence supports the working hypothesis that endometrial-and conceptus-derived PGs regulate endometrial HSD11B1 expression and activity, which regenerates cortisol to regulate endometrial functions and conceptus elongation in sheep. The present studies represent the first step in testing that hypothesis.
MATERIALS AND METHODS

Experimental Design
Mature Rambouillet ewes (Ovis aries) were observed for onset of estrus (designated Day 0 of the estrous cycle or pregnancy) in the presence of a vasectomized ram and used in experiments only after exhibiting at least two estrous cycles of normal duration (16-18 days) . All the experimental and surgical procedures were in compliance with the Guide for the Care and Use of Agriculture Animals in Research and Teaching and approved by the Institutional Animal Care and Use Committee of Texas A&M University.
Study one. Ewes were mated to an intact ram of proven fertility on Days 0 and 1 and then hysterectomized (n ¼ 5/day) on either Day 12, 13, 14, 15, or 16 of pregnancy. At hysterectomy, pregnancy was confirmed by the presence of a morphologically normal blastocyst/conceptus in the uterine flushing. The ipsilateral uterine horn was flushed with 10 ml of 10 mM Tris, pH 7.2, and the state of conceptus development was visually assessed and recorded. Endometrial tissue (;1 g) from Days 12 to 16 of pregnancy as well as Day 14, 15, and 16 conceptuses (n ¼ 5/day) were used for HSD11B1 activity assays.
Study two. Ewes (n ¼ 10) were mated at estrus (Day 0) to rams of proven fertility. On Day 8 postmating, the ewes were subjected to a midventral laparotomy. Using methods described previously [29, 30] , the base of the uterine horn ipsilateral to the CL was double ligated using nonabsorbable umbilical tape to prevent migration and growth of the conceptus through the uterine body into the contralateral uterine horn; this surgical procedure does not affect conceptus implantation or development in sheep [30] . A vinyl catheter (0007760; Durect Corporation), connected to a preloaded and equilibrated Alzet 2ML1 osmotic pump (Durect Corporation), was then inserted about 1 cm distal to the tubo-uterine junction into the lumen of the uterine horn ipsilateral to the ovary containing a CL. The Alzet pump was then affixed to the mesosalpinx supporting the oviduct using cyanoacrylate glue (Super-Glue) and then secured by suturing the mesosalpinx to the perimetrium of the uterine horn using 0 Coated Vicryl suture (Ethicon).
Ewes (n ¼ 5/treatment) received osmotic pumps containing either 1) 2 ml of control vehicle (CX; 2% ethanol [v/v] in saline) or 2) 1225 ng MEL (Boehringer Ingelheim Pharmaceuticals) in 2 ml vehicle; MEL is a partially selective PTGS2 inhibitor (13.1 times more inhibitory for PTGS2 than PTGS1) [31] that is effective in sheep [32] [33] [34] [35] [36] [37] . The Alzet 2ML1 osmotic pump constantly delivers 10 ll per h (240 ll/day) for 7 days. All the ewes were euthanized on Day 14 postmating to obtain the uterus. The ipsilateral uterine horn was flushed with 10 ml of 10 mM Tris (pH 7.2), and the state of conceptus development was visually assessed and recorded. The volume of the uterine flushing was measured and recorded, and then clarified by centrifugation (3000 3 g at 48C for 15 min). The supernatant was carefully removed with a pipet, aliquoted, frozen in liquid nitrogen, and stored at À808C. Several sections (;0.5 cm) from the midportion of each uterine horn were embedded in optimal cutting temperature compound (Miles, Inc.), snap-frozen in liquid nitrogen, and stored at À808C. Sections of the uterine wall were also fixed in fresh 4% paraformaldehyde (w/v) in PBS, pH 7.2. After 24 h, fixed tissues were changed to 70% ethanol (v/v) for 24 h and then dehydrated and embedded in ParaplastPlus (Oxford Labware). The remaining endometrium was physically dissected from myometrium using curved scissors, frozen in liquid nitrogen, and stored at À808C for subsequent RNA extraction.
Study three. Ewes (n ¼ 24) were detected in estrus (Day 0) using a vasectomized ram. On Day 10 postestrus, ewes were subjected to a midventral laparotomy, and the lumen of each uterine horn received a vinyl catheter connected to an Alzet 2ML1 osmotic pump that was implanted as described for study one. Ewes (n ¼ 6/treatment) received pumps containing either 1) 2 ml vehicle and 101 lg of ovine serum proteins; 2) 101 lg recombinant ovine IFNT in 2 ml vehicle; 3) 1225 ng MEL in 2 ml vehicle and 101 lg of ovine serum proteins; or 4) recombinant ovine IFNT and MEL (IFNTþMEL). Recombinant ovine IFNT was produced in Pichia pastoris and purified as described previously [38] . Serum proteins and IFNT were prepared for intrauterine injections as described previously [39] . The amount of recombinant ovine IFNT was based on published estimates of IFNT production by Day 14 ovine conceptuses, which is about 600 ng/h or 14.4 lg/day [40] . Intrauterine infusion of that amount of IFNT mimics the effects of the conceptus on endometrial expression of hormone receptors and IFNT-stimulated genes during early pregnancy in ewes [41] . All the ewes were necropsied on Day 14, and uterine flushings and uteri were obtained and processed as described for study one.
Study four. Ewes (n ¼ 30) were checked daily for estrus (Day 0) and subjected to a midventral laparotomy and fitted with an Alzet 2ML1 osmotic pump (n ¼ 5 ewes/treatment) on Day 10 postestrus. The pumps constantly infused vehicle (CX), 101 lg recombinant ovine IFNT, 251 ng PGE2, 409 ng PGF2a, or 1483 ng PGI2 into the lumen of each uterine horn each day to mimic production by elongating Day 14 ovine conceptuses [25, 26, 42] . All the ewes were necropsied on Day 14 to obtain uterine flushings, and the uteri were processed as described for study one.
Total RNA Isolation and Real-Time PCR Analysis
Total RNA was isolated from endometria as described previously [14] . Total RNA from each sample was reverse transcribed in a total reaction volume of 20 ll. Briefly, total RNA (4 lg) was combined with primer mix containing oligo (dT) primer (0.2 lg/ml), random hexamer primer (300 lg/ml) (Invitrogen), and dNTP mix (10 mM each), and incubated at 658C for 5 min. A reverse transcriptase mix containing 53 first-strand buffer, 100 mM DTT (dithiothreitol) and SuperScript II reverse transcriptase (Invitrogen) was added to the reaction, and reverse transcription was performed under the following conditions: 258C for 10 min, 428C for 60 min, and 708C for 5 min. Control reactions in the absence of reverse transcriptase were prepared for each sample to test for contamination with genomic DNA. The resulting cDNA was stored at À208C for further analysis.
Real-time PCR was performed using ABI prism 7900HT system (Applied Biosystems) with Power SYBR Green PCR Master Mix (Applied Biosystems). Specific oligonucleotide primers were designed by Oligo 5 program (Molecular Biology Insights, Inc.) (see Supplemental Table S1 ; available online at www. biolreprod.org). Primer specificity and efficiency (À3.6 . slope . À3.1) were confirmed using a test amplification run. Each individual sample was run in triplicate under the following conditions: 508C for 2 min; 958C for 10 min; 958C for 15 sec and 608C for 1 min for 40 cycles. A dissociation curve was generated at the end of the amplification to ensure that a single product was amplified. PCR without template or template substituted with total RNA was used as a negative control to verify the experimental results. The threshold line was set in the linear region of the plots above the baseline noise, and threshold cycle (Ct) values were determined as the cycle number at which the threshold line crossed the amplification curve. Ovine GAPDH was used as the reference gene.
RT-PCR of Ovine H6PD
A partial cDNA for ovine H6PD was amplified by RT-PCR using total RNA isolated from endometria of Day 16 pregnant ewes and methods described previously [14] . The sense primer (5 0 -GGT GTC CCG TTC ATC CT-3 0 ) and antisense primer (5 0 -GTC CGT TCT CTG CTC CTC CT-3 0 ) were derived from the Bos taurus H6PD mRNA coding sequence (GenBank accession no. XM_002694063) and amplified a 478-bp product. Partial ovine cDNAs were cloned into pCRII using Cloning Kit (Invitrogen), and the sequence was verified using an ABI PRISM Dye Terminator Cycle Sequencing DORNIAK ET AL.
Kit and ABI PRISM automated DNA sequencer (Perkin-Elmer Applied Biosystems).
Bioassay of HSD11B1 Activity
HSD11B1 reductase activity was quantified by measuring the net rate of conversion of cortisone to cortisol as described by Lee and coworkers [19] with modifications. Samples of endometria and conceptus (150 mg) were placed in a culture dish (Corning Costar) with 6 ml MEM (Sigma-Aldrich Co.) containing 0.1% (w/v) bovine serum albumin (BSA) (Sigma), penicillin (100 units/ml), and streptomycin (100 lg/ml). Endometrial explants were incubated with vehicle as a control or cortisone (3 lM final). To examine nonspecific interconversion, cortisone (3 lM final) was added to the medium in the absence of tissue (blank). All the incubations were performed in triplicate. Endometrial explants and blanks were placed on a slowly rotating orbital shaker within the incubator at 378C in a humidified atmosphere of 5% carbon dioxide in air for 4 h. After this period, the medium was collected and stored at À208C until assayed for cortisol using a radioimmunoassay. The rate of conversion of cortisone to cortisol is expressed as pg cortisol/mg tissue/h.
Radioimmunoassay of Cortisol
Concentrations of cortisol in culture medium were determined using a single antibody-charcoal separation assay described previously [43] . Counts per minute were obtained from a liquid scintillation spectrophotometric betacounter (Beckman Coulter LS 6500). Radioimmunoassay data were processed using Assay Zap software (Biosoft). The detection limit for cortisol was 15.6 pg/ml, and the intra-and interassay coefficients of variation were 4.7% and 9.0%, respectively. Rabbit anti-cortisol antiserum (Pantex) was used with a cross-reactivity of 60%, 48%, 0.01%, and 0.01% with corticosterone, deoxycorticosterone, P4, and estradiol, respectively.
Enzyme Immunoassay of Cortisol
A sensitive enzyme immunoassay kit from Cayman Chemical (500360) was used according to the manufacturer's recommendations to determine the amount of cortisol in uterine flushings collected in studies two, three, and four. Assay sensitivity for cortisol was 6.6 pg/ml and the intra-and inter-assay coefficients of variation were 3.6% and 7.4%, respectively. The data are expressed as total amount of cortisol in the uterine lumen determined by multiplying assay results by the recovered volume of the uterine flushing.
In Situ Hybridization Analysis
Localization of H6PD mRNA in the ovine uterus was determined by radioactive in situ hybridization analysis using methods described previously [16, 44, 45] . Briefly, radiolabeled antisense and sense cRNA probes were generated by in vitro transcription using linearized partial plasmid cDNA template, RNA polymerases, and [a-
35 S]-uridine triphosphate (UTP). Deparaffinized, rehydrated, and deproteinated uterine tissue sections were hybridized with radiolabeled antisense or sense cRNA probes. After hybridization, washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic emulsion (Kodak) and exposed at 48C for 10 days based on the intensity of radioactive signal of slides placed on Kodak MR film for 16 h. All the slides were exposed to photographic emulsion for the same period. Slides were developed in Kodak D-19 developer, counterstained with Gill hematoxylin (Fisher Scientific), and dehydrated through a graded series of alcohol to xylene; the coverslips were then affixed with Permount (Fisher Scientific). Images of representative fields were recorded under bright-field or dark-field illumination using a Nikon Eclipse 1000 photomicroscope (Nikon Instruments Inc.) fitted with a Nikon DXM1200 digital camera.
Immunofluorescence
Immunoreactive HSD11B1 and HSD11B2 protein was detected in ovine uteri by immunofluorescence staining as described previously [46] . Frozen tissues were sectioned (8 lm) using a Leica CM1850 Cryostat (Leica Microsystems) and mounted on microscope slides (Fisher Scientific). Frozen sections were fixed in À208C methanol for 10 min, permeabilized with 0. , and one part glycerol) containing 5% normal goat serum (v/v) for 1 h at room temperature, and incubated overnight at 48C with rabbit anti-human HSD11B1 polyclonal antibody (GTX104626S; GeneTex) at 5 lg/ml or rabbit anti-human HSD11B2 polyclonal antibody (GTX109786; GeneTex) at 5 lg/ml. Negative controls included substitution of the primary antibody with purified nonimmune rabbit immunoglobulin G (IgG) at the same final concentration. Immunoreactive protein was then detected using a fluorescein-conjugated goat anti-rabbit secondary antibody (10006588; Cayman Chemical) for 1 h at room temperature. Slides were overlaid with Prolong antifade mounting reagent and then coverslips added (Molecular Probes). Photomicrographs were taken using a Nikon Eclipse E1000 photomicroscope (Nikon Instruments). Digital images were captured using a Nikon DXM 1200 digital camera and assembled using Adobe Photoshop 7.0 (Adobe Systems).
Statistical Analysis
All the quantitative data were subjected to least-squares analyses of variance (ANOVA) using the general linear models procedures of the Statistical Analysis System (SAS Institute Inc.). In studies two, three, and four, preplanned orthogonal contrasts were used to determine the effects of the treatments. For the analysis of real-time PCR data, the Ct values of the target mRNA was analyzed for effects of treatment and their interaction with the GAPDH values used as a covariate. In all the analyses, the error terms used in tests of significance were identified according to the expectation of the mean squares for error. Significance (P , 0.05) was determined by probability differences of least-squares means. The HSD11B1 activity and cortisol data are presented as least-squares means and overall standard error (SEM). The realtime PCR data are presented as fold change relative to the mRNA level in the treatment group with the highest Ct value.
RESULTS
HSD11B1 Activity During Early Pregnancy (Study One)
As illustrated in Figure 1A , endometrial HSD11B1 activity was highest on Days 12 and 13 of early pregnancy (P , 0.05, quadratic effect of day). HSD11B1 activity in the conceptus was not different (P . 0.10) on Days 14, 15, and 16 (Fig. 1B) . Of note, HSD11B1 activity was approximately 15-, 14-, and 19-fold greater in the conceptus than endometrium on Days 14, 15, and 16 of pregnancy, respectively, on a per mg tissue basis.
Intrauterine Infusion of PTGS2 Inhibitor Reduces Endometrial HSD11B1 Activity and Cortisol Regeneration in the Uterine Lumen (Study Two)
Study two tested the hypothesis that conceptus-and/or endometrial-derived PGs regulate HSD11B1 activity in the endometrium. As described previously [14] , infusion of the selective PTGS2 inhibitor MEL into the uterine lumen from Days 8 to 14 of pregnancy inhibited conceptus elongation. Both total cortisol in the uterine lumen and endometrial HSD11B1 activity were 11-and 2-fold greater, respectively, (P , 0.01) in CX than MEL-treated ewes (Table 1) .
IFNT Increases Endometrial HSD11B1 mRNA Abundance and Activity and Regeneration of Cortisol in Uterine Lumen of Cyclic Ewes (Study Three)
Study three tested the hypothesis that the effects of ovarian P4 and conceptus IFNT on endometrial HSD11B1 expression and HSD11B1 activity are mediated by PGs (Fig. 2A) . As compared to CX ewes, HSD11B1 mRNA was reduced (CX vs. MEL, P , 0.01) in endometria of ewes receiving MEL, a PTGS2 inhibitor. Intrauterine infusion of IFNT increased endometrial HSD11B1 mRNA abundance (CX vs. IFNT, P , 0.01), whereas coinfusion of MEL decreased the effects of IFNT on HSD11B1 expression (IFNT vs. IFNTþMEL, P , 0.01). Similarly, endometrial H6PD mRNA levels were increased by IFNT (CX vs. IFNT, P , 0.01), and that increase was abolished by coinfusion with MEL (IFNT vs. IFNTþMEL, P , 0.01). Infusion of IFNTþMEL increased (P , 0.01) endometrial HSD11B2 mRNA abundance.
In situ hybridization analyses revealed that H6PD mRNA was most abundant in the endometrial LE and GE and to lesser ENDOMETRIAL HSD11B1 AND CORTISOL REGENERATION IN THE OVINE UTERUS extent in the stroma (Fig. 2B) . As shown in Figure 3 , immunoreactive HSD11B1 protein was increased in the endometrial LE and GE of ewes treated with IFNT. Immunoreactive HSD11B2 protein was low in the endometrium of CX ewes and increased in the LE and stroma by infusion of IFNT, MEL, or IFNTþMEL.
As illustrated in Figure 4 , endometrial HSD11B1 activity and total cortisol in the uterine lumen were not different (P . 0.10) between CX and MEL-treated ewes. In contrast, endometrial HSD11B1 activity and cortisol in the uterine lumen was higher (P , 0.05) in IFNT as compared to CX and MEL ewes. Coinfusion of MEL with IFNT reduced HSD11B1 activity and cortisol in the uterine lumen (IFNT vs. IFNTþMEL, P , 0.05).
HSD11B1 mRNA Abundance and Activity Is Increased by PGs (Study Four)
Study four tested the hypothesis that conceptus-derived factors (IFNT and PGs) regulate endometrial HSD11B1 expression and HSD11B1 activity during early pregnancy. As shown in Figure 5A , intrauterine infusion of IFNT, PGE2, PGF2a, and PGI2 increased (P , 0.01) endometrial HSD11B1 mRNA abundance as compared with CX ewes by approximately 6.0-, 2.8-, 3.9-, and 5.3-fold, respectively. Infusion of IFNT increased HSD11B2 mRNA abundance (IFNT vs. CX, P , 0.01). Although PGE2 and PGF2a had no effect (P . 0.10) on endometrial HSD11B2 expression, intrauterine infusion of PGI2 decreased endometrial HSD11B2 mRNA by 1.6-fold (CX vs. PGI2, P , 0.01).
Intrauterine infusion of IFNT and PGI2 increased (P , 0.01) endometrial H6PD mRNA levels (Fig. 5A) . In situ hybridization analysis found that effects of IFNT and PGI2 on H6PD expression were manifest primarily in the LE and GE of the endometrium (Fig. 5B) . As shown in Figure 6 , IFNT and all the infused PGs increased the abundance of HSD11B1 protein in endometrial LE and GE of ewes in study four. Immunoreactive HSD11B2 protein was low in the endometrium of CX ewes and increased in the LE and stroma by infusion of IFNT and PGF2a.
As illustrated in Figure 7 , infusion of both IFNT and PGI2 increased (P , 0.05) endometrial HSD11B1 activity and cortisol in the uterine lumen. Although infusion of PGE2 and PGF2a increased (P , 0.05) HSD11B1 activity in the endometrium, cortisol in the uterine lumen was not different (P . 0.10) in ewes receiving infusions of PGE2 and PGF2a as compared to CX ewes.
DISCUSSION
The results of the present studies support the idea that IFNT and PGs from the conceptus and endometrium stimulate endometrial epithelial HSD11B1 expression and HSD11B1 activity to increase regeneration of cortisol from cortisone during early pregnancy in sheep (see Fig. 8 ). We previously reported that MEL inhibits PTGS2 activity in the ovine endometrium [14] . In study two, infusion of MEL into the uterine lumen from Days 8 to 14 postmating reduced cortisol in the uterine lumen and endometrial HSD11B1 activity. The two-fold decrease in HSD11B1 activity in the endometria of pregnant ewes treated with MEL may not explain the 10-fold decrease in cortisol in the uterine lumen because HSD11B1 activity was much higher in the conceptus than in the endometrium on Days 14 to 16 of pregnancy. Thus, the elongating ovine conceptus also regenerates cortisol from cortisone to increase the amount of cortisol in the uterine lumen. Cortisol may regulate endometrial and conceptus functions during early pregnancy, given that NR3C1 receptors are present in both the conceptus and endometrium [16] . The conceptus is likely protected from excess cortisol action because HSD11B2 is abundantly expressed in the trophectoderm and endoderm of Days 18 and 20 ovine conceptuses [16] , converting biologically active cortisol to inactive cortisone. Similarly, HSD11B2 is abundantly expressed and functional in first trimester trophoblast cells of human placentae where it has been implicated in modulating exposure of the embryo to active glucocorticoids in early gestation and in regulating trophoblast migration during placentation [47] .
The actions of ovarian P4 are essential for conceptus survival and growth in sheep because conceptuses are lost in ewes treated with mifepristone (RU486), a progesterone [48] . Expression of many genes in the endometrial LE/sGE that regulate conceptus elongation is initiated between Days 10 and 12 postestrus/mating in both cyclic and pregnant ewes (see [8, 49] for review). Action of P4 for 8 to 10 days induces expression of many elongation-and implantation-related genes in the endometrial LE/sGE, including HSD11B1 and PTGS2 [16, 24, 50] . Results of study three provide evidence that PTGS2-derived PGs mediate P4 effects on endometrial HSD11B1 expression because intrauterine infusion of MEL reduced the ability of P4 to induce HSD11B1 expression in the endometrium. In the uterine LE/sGE, HSD11B1 is coexpressed with PTGS2 specifically between Days 12 and 14 of pregnancy in sheep, and the subsequent decline in HSD11B1 expression between Days 16 and 20 is temporally associated with changes in the pattern of production of PGs by the conceptus and amounts of PGs in the uterine lumen [16, 25, 27, 42] . In the endometrial LE/sGE, P4 induces and IFNT increases expression of HSD11B1 [15, 16] . In the present study, infusion of MEL partially attenuated the effects of IFNT on H6PD and HSD11B1 expression and HSD11B1 activity in the endometrium. Collectively, the available results support the ideas that actions of P4 and IFNT on endometrial HSD11B1 expression and HSD11B1 activity are mediated, in part, by PGs.
We previously found that P4 induced and IFNT stimulated HSD11B1 expression specifically in the endometrial LE/sGE of the ovine uterus [15, 16] . In study three, IFNT infusion also increased HSD11B1 mRNA and HSD11B1 protein in the LE and GE of the endometrium. The effects of IFNT on HSD11B1 expression were reduced by infusion of MEL, and HSD11B1 was absent from GE, but not LE, of ewes treated with IFNT and MEL. These results and others [14] implicate PTGS2-derived PGs as mediators of IFNT action within the endometrium. Although IFNT clearly silences ESR1 transcription that inhibits up-regulation of OXTR expression in endometrial LE/sGE of pregnant ewes, it does not inhibit upregulation of PTGS2, a rate-limiting enzyme in PG synthesis [24, 51] . The endometrium also contains and produces substantially more PGs during early pregnancy than during the estrous cycle in sheep and cattle [28, 42] . We recently reported that IFNT stimulated PTGS2 activity in the endometrium of sheep [14] . Similarly, PTGS2 is also not downregulated in endometria of early pregnant cattle but rather is up-regulated by IFNT [52, 53] . The cellular and molecular pathways utilized by IFNT to regulate HSD11B1 expression 
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and PTGS2 activity in the endometrial LE are unknown. Although receptors for IFNT are most abundant on endometrial epithelia, the canonical janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway mediating effects of IFNT in the stroma and GE is not active in endometrial LE/sGE due to expression of IFN regulatory factor 2 (IRF2), a potent transcriptional repressor of STAT1, STAT2, and IRF9 genes [12, [54] [55] [56] . IFNT may regulate endometrial epithelial gene expression using a noncanonical signaling pathway, such as the mitogen-activated protein kinase and phosphatidylinositol-3 kinase cascades reported for other IFNs [57] . In sheep and cattle, the conceptus and endometrium synthesize a variety of PGs during early pregnancy [24-27, 58, 59] . Between Days 12 and 16 of pregnancy, sheep conceptuses in vitro release mainly cyclooxygenase metabolites that include PGE2, PGF2a, and 6-keto-PGF1a, a metabolite of PGI2 [25] . Results of study four revealed that infusion of IFNT, PGE2, PGF2a, and PGI2 into the uterine lumen increased endometrial HSD11B1 expression and HSD11B1 activity. All the PGs increased HSD11B1 protein in the GE and to a lesser extent in the LE of the endometrium. Further, IFNT and PGI2 stimulated endometrial H6PD expression in the endometrium. A high NADPH to NADP þ ratio generated by H6PD causes HSD11B1 to act predominately as a keto-reductase to generate active cortisol [18] . Collectively, these results support the hypothesis that IFNT and conceptus-and endometrial-derived PGI2 stimulate regeneration of active cortisol via HSD11B1 in the endometrium during early pregnancy in sheep (see Fig. 8 ).
Cortisol regenerated from cortisone in the endometrium and conceptus is proposed to activate NR3C1 receptors and regulate expression of target genes in the endometrium as well as the conceptus trophectoderm during early pregnancy (see Fig. 8 ). Indeed, NR3C1 protein is present in all endometrial cells of ovine uterus during the estrous cycle and pregnancy and in the conceptus trophectoderm [14, 16] . Relatively little is known regarding the biological activities of glucocorticoids in ruminants during early pregnancy. Of interest, pregnancy rates are greater in woman undergoing standard in vitro fertilization who receive synthetic glucocorticoids prior to or immediately after embryo transfer [60] . On the other hand, NR3C1 may be activated by P4 to regulate gene expression in LE/sGE, as PGR are absent from those epithelia and because P4 regulates gene expression in human trophoblast cells via an interaction with NR3C1 [61, 62] . Collectively, the available results support our central hypotheses that ovarian P4 induces PTGS2 and 
FIG. 7.
Total recoverable cortisol in uterine flushings and HSD11B1 enzymatic activity in endometria from cyclic ewes infused with vehicle as a control (CX), recombinant ovine interferon tau (IFNT), PGE2, PGF2a (PGF2), or PGI2. The quantity of cortisol in uterine flushings was measured by enzyme immunoassay and presented as total amount (ng). Endometrial HSD11B1 activity was assayed by measuring the net rate of conversion of cortisone to cortisol in vitro, and cortisol was determined by radioimmunoassay. Data are presented as pg cortisol/mg tissue/h. *Effect of treatment (P , 0.01).
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HSD11B1 expression and conceptus factors (IFNT and PGs) stimulate endometrial PTGS2 activity and HSD11B1 expression and activity, which produces PGs and regenerates cortisol that, in turn, regulates endometrial and conceptus functions important for conceptus elongation during early pregnancy (see Fig. 8 ). Future studies will focus on the biological roles of cortisol in the regulation of endometrial functions and conceptus elongation during pregnancy.
